Hypoxaemia in sickle cell disease: biomarker modulation and relevance to pathophysiology.

PubWeight™: 2.15‹?› | Rank: Top 2%

🔗 View Article (PMID 14602439)

Published in Lancet on November 01, 2003

Authors

B N Yamaja Setty1, Marie J Stuart, Carlton Dampier, Darcy Brodecki, Julian L Allen

Author Affiliations

1: Department of Pediatrics and the Marian Anderson Sickle Cell Center Core Laboratory, Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA 19107, USA.

Associated clinical trials:

Algorithm for Apherisis Monitoring and Prescription Assistance in Sickle Cell Patients (ALGODREP) (ALGODREP) | NCT04076683

Articles citing this

Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes. Blood Rev (2006) 4.46

Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease. Blood (2005) 3.98

Elevated tricuspid regurgitant jet velocity in children and adolescents with sickle cell disease: association with hemolysis and hemoglobin oxygen desaturation. Haematologica (2009) 2.20

Left ventricular hypertrophy and diastolic dysfunction in children with sickle cell disease are related to asleep and waking oxygen desaturation. Blood (2010) 2.19

Placenta growth factor augments endothelin-1 and endothelin-B receptor expression via hypoxia-inducible factor-1 alpha. Blood (2008) 2.09

Clinical correlates of steady-state oxyhaemoglobin desaturation in children who have sickle cell disease. Br J Haematol (2005) 1.86

Levels of soluble endothelium-derived adhesion molecules in patients with sickle cell disease are associated with pulmonary hypertension, organ dysfunction, and mortality. Br J Haematol (2005) 1.69

Daytime steady-state haemoglobin desaturation is a risk factor for overt stroke in children with sickle cell anaemia. Br J Haematol (2007) 1.43

Cardiopulmonary complications of sickle cell disease: role of nitric oxide and hemolytic anemia. Hematology Am Soc Hematol Educ Program (2005) 1.36

Daytime pulse oximeter measurements do not predict incidence of pain and acute chest syndrome episodes in sickle cell anemia. J Pediatr (2006) 1.30

Pleiotropic effects of intravascular haemolysis on vascular homeostasis. Br J Haematol (2009) 1.20

Haemoglobin oxygen saturation is a determinant of cerebral artery blood flow velocity in children with sickle cell anaemia. Br J Haematol (2009) 1.18

Sleep disturbances in school-age children with chronic pain. J Pediatr Psychol (2007) 1.12

Prospective evaluation of haemoglobin oxygen saturation at rest and after exercise in paediatric sickle cell disease patients. Br J Haematol (2009) 1.12

An observational study of children with sickle cell disease in Kilifi, Kenya. Br J Haematol (2009) 1.09

Angiogenic and inflammatory markers of cardiopulmonary changes in children and adolescents with sickle cell disease. PLoS One (2009) 1.07

Markers of severe vaso-occlusive painful episode frequency in children and adolescents with sickle cell anemia. J Pediatr (2011) 1.05

Microvascular endothelial cells express a phosphatidylserine receptor: a functionally active receptor for phosphatidylserine-positive erythrocytes. Blood (2007) 1.03

Evolution of novel small-molecule therapeutics targeting sickle cell vasculopathy. JAMA (2008) 1.02

Hypoxic adaptation during development: relation to pattern of neurological presentation and cognitive disability. Dev Sci (2006) 1.01

Increased levels of the inflammatory biomarker C-reactive protein at baseline are associated with childhood sickle cell vasocclusive crises. Br J Haematol (2009) 1.00

Increased von Willebrand factor antigen and high molecular weight multimers in sickle cell disease associated with nocturnal hypoxemia. Thromb Res (2008) 0.96

Sickle Cell Disease in the Post Genomic Era: A Monogenic Disease with a Polygenic Phenotype. Genomics Insights (2009) 0.96

Tissue factor-positive monocytes in children with sickle cell disease: correlation with biomarkers of haemolysis. Br J Haematol (2012) 0.95

Polysomnographic characteristics of a referred sample of children with sickle cell disease. J Clin Sleep Med (2010) 0.94

Tapered oral dexamethasone for the acute chest syndrome of sickle cell disease. Br J Haematol (2011) 0.92

Laboratory and echocardiography markers in sickle cell patients with leg ulcers. Am J Hematol (2011) 0.89

Non-invasive measurements of carboxyhemoglobin and methemoglobin in children with sickle cell disease. Pediatr Pulmonol (2012) 0.89

Priapism in sickle cell anemia: emerging mechanistic understanding and better preventative strategies. Anemia (2010) 0.87

Upper airway lymphoid tissue size in children with sickle cell disease. Chest (2012) 0.85

Emerging biobehavioral factors of fatigue in sickle cell disease. J Nurs Scholarsh (2011) 0.84

Severe nocturnal and postexercise hypoxia in children and adolescents with sickle cell disease. PLoS One (2014) 0.84

Hematological and Genetic Predictors of Daytime Hemoglobin Saturation in Tanzanian Children with and without Sickle Cell Anemia. ISRN Hematol (2013) 0.84

Crosstalk between red blood cells and the immune system and its impact on atherosclerosis. Biomed Res Int (2015) 0.82

Hematologic and hemorheological determinants of resting and exercise-induced hemoglobin oxygen desaturation in children with sickle cell disease. Haematologica (2013) 0.81

Sickle cell anemia: iron availability and nocturnal oximetry. J Clin Sleep Med (2012) 0.80

Stroke in Children with Sickle Cell Disease. Curr Treat Options Neurol (2004) 0.79

Reduction of the six-minute walk distance in children with sickle cell disease is correlated with silent infarct: results from a cross-sectional evaluation in a single center in Belgium. PLoS One (2014) 0.78

Prevention of Morbidity in sickle cell disease--qualitative outcomes, pain and quality of life in a randomised cross-over pilot trial of overnight supplementary oxygen and auto-adjusting continuous positive airways pressure (POMS2a): study protocol for a randomised controlled trial. Trials (2015) 0.75

Author's Reply. Pulm Circ (2013) 0.75

Nocturnal haemoglobin oxygen saturation variability is associated with vitamin C deficiency in Tanzanian children with sickle cell anaemia. Acta Paediatr (2010) 0.75

Arterial ischemic stroke in children: risk factors and etiologies. Curr Neurol Neurosci Rep (2014) 0.75

Hydroxyurea Improves Oxygen Saturation in Children With Sickle Cell Disease. J Pediatr Hematol Oncol (2015) 0.75

Physical activity level and performance in the six-minute walk test of children and adolescents with sickle cell anemia. Rev Bras Hematol Hemoter (2017) 0.75

Prevalence of obstructive sleep apnea in children with sickle cell disease at a tertiary hospital in Saudi Arabia. Saudi Med J (2017) 0.75

Articles by these authors

An official American Thoracic Society/European Respiratory Society statement: pulmonary function testing in preschool children. Am J Respir Crit Care Med (2007) 4.10

Home management of pain in sickle cell disease: a daily diary study in children and adolescents. J Pediatr Hematol Oncol (2002) 1.94

Beliefs and barriers to follow-up after an emergency department asthma visit: a randomized trial. Pediatrics (2009) 1.67

Role of erythrocyte phosphatidylserine in sickle red cell-endothelial adhesion. Blood (2002) 1.47

Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management. ScientificWorldJournal (2012) 1.40

Nitric oxide for inhalation in the acute treatment of sickle cell pain crisis: a randomized controlled trial. JAMA (2011) 1.38

Quality of life among adolescents with sickle cell disease: mediation of pain by internalizing symptoms and parenting stress. Health Qual Life Outcomes (2008) 1.22

Characteristics of pain managed at home in children and adolescents with sickle cell disease by using diary self-reports. J Pain (2002) 1.22

Vaso-occlusion in children with sickle cell disease: clinical characteristics and biologic correlates. J Pediatr Hematol Oncol (2004) 1.10

Severity of obstructive sleep apnea in children with sickle cell disease. J Pediatr Hematol Oncol (2008) 1.08

Pulmonary complications of sickle cell disease in children. Curr Opin Pediatr (2008) 1.05

Development and validation of an instrument to measure asthma symptom control in children. J Asthma (2006) 1.04

A prospective study of the role of coping and family functioning in health outcomes for adolescents with sickle cell disease. J Pediatr Hematol Oncol (2007) 1.04

Sleep patterns in pediatric sickle cell disease. Pediatr Blood Cancer (2010) 1.03

Increased levels of the inflammatory biomarker C-reactive protein at baseline are associated with childhood sickle cell vasocclusive crises. Br J Haematol (2009) 1.00

Caregiver report of pain in infants and toddlers with sickle cell disease: reliability and validity of a daily diary. J Pain (2002) 0.96

Increased von Willebrand factor antigen and high molecular weight multimers in sickle cell disease associated with nocturnal hypoxemia. Thromb Res (2008) 0.96

Tissue factor-positive monocytes in children with sickle cell disease: correlation with biomarkers of haemolysis. Br J Haematol (2012) 0.95

High dose vitamin D therapy for chronic pain in children and adolescents with sickle cell disease: results of a randomized double blind pilot study. Br J Haematol (2012) 0.94

Physical and cognitive-behavioral activities used in the home management of sickle pain: a daily diary study in children and adolescents. Pediatr Blood Cancer (2004) 0.93

Vitamin D deficiency and chronic pain in sickle cell disease. Br J Haematol (2011) 0.93

Tapered oral dexamethasone for the acute chest syndrome of sickle cell disease. Br J Haematol (2011) 0.92

Gene network analysis in a pediatric cohort identifies novel lung function genes. PLoS One (2013) 0.90

Respiratory inductance plethysmography in healthy 3- to 5-year-old children. Chest (2003) 0.89

Non-invasive measurements of carboxyhemoglobin and methemoglobin in children with sickle cell disease. Pediatr Pulmonol (2012) 0.89

Respiratory muscle force and lung volume changes in a population of children with sickle cell disease. Br J Haematol (2013) 0.88

Symptoms of depression and anxiety in adolescents with sickle cell disease: the role of intrapersonal characteristics and stress processing variables. Child Psychiatry Hum Dev (2009) 0.88

Eicosanoids in sickle cell disease: potential relevance of neutrophil leukotriene B4 to disease pathophysiology. J Lab Clin Med (2002) 0.85

Upper airway lymphoid tissue size in children with sickle cell disease. Chest (2012) 0.85

Peripheral arterial tonometry in assessing endothelial dysfunction in pediatric sickle cell disease. Pediatr Hematol Oncol (2009) 0.84

Technology supporting research and quality improvement: a success story. J Pediatr Nurs (2011) 0.82

Upper airway genioglossal activity in children with sickle cell disease. Sleep (2011) 0.81

Noninvasive measurement of the tension-time index in children with neuromuscular disease. J Appl Physiol (1985) (2003) 0.81

Psychosocial and Functional Outcomes in Youth With Chronic Sickle Cell Pain. Clin J Pain (2016) 0.80

Pain characteristics and age-related pain trajectories in infants and young children with sickle cell disease. Pediatr Blood Cancer (2013) 0.78

Salmonella infection associated with a pet lizard in siblings with sickle cell anemia: an avoidable risk. J Pediatr Hematol Oncol (2002) 0.76

Infant pulmonary function testing. Curr Opin Pediatr (2003) 0.76

Treatment of empyema in children: from Hippocrates' time to the present, and back again. Am J Respir Crit Care Med (2006) 0.75

Treatment of respiratory system (not just lung!) abnormalities in Mucopolysaccharidosis I. J Pediatr (2004) 0.75

Claim-based analyses of inhaled corticosteroid refill rates for asthma: who's kidding whom? Ann Am Thorac Soc (2013) 0.75

Stigma and Pain in Adolescents Hospitalized for Sickle Cell Vaso-occlusive Pain Episodes. Clin J Pain (2017) 0.75

Development and validation of the self-reported PROMIS pediatric pain behavior item bank and short form scale. Pain (2017) 0.75

Trisomy 11 limited to trisomy 21 cells in a mosaic Down syndrome child with acute myeloid leukemia. Med Pediatr Oncol (2003) 0.75

Management of refractory pain in hospitalized adolescents with sickle cell disease: changing from intravenous opioids to continuous infusion epidural analgesia. J Pediatr Hematol Oncol (2014) 0.75